GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Current Accrued Expense

Biomics Biopharma (ASX:BBM) Current Accrued Expense : A$0.00 Mil (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Current Accrued Expense?

Biomics Biopharma's Current Accrued Expense for the quarter that ended in . 20 was A$0.00 Mil.


Biomics Biopharma Current Accrued Expense Historical Data

The historical data trend for Biomics Biopharma's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Current Accrued Expense Chart

Biomics Biopharma Annual Data
Trend
Current Accrued Expense

Biomics Biopharma Semi-Annual Data
Current Accrued Expense

Biomics Biopharma Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Biomics Biopharma Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomics Biopharma (ASX:BBM) Business Description

Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines